NO20034722L - Nye imidazolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents

Nye imidazolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Info

Publication number
NO20034722L
NO20034722L NO20034722A NO20034722A NO20034722L NO 20034722 L NO20034722 L NO 20034722L NO 20034722 A NO20034722 A NO 20034722A NO 20034722 A NO20034722 A NO 20034722A NO 20034722 L NO20034722 L NO 20034722L
Authority
NO
Norway
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
imidazoline compounds
Prior art date
Application number
NO20034722A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034722D0 (no
Inventor
Jean-Guy Bizot-Espiard
Sylvain Rault
Jean-Charles Lancelot
Pierre Renard
Marine Kopp
Stephane Lemaitre
Daniel-Henri Caignard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20034722D0 publication Critical patent/NO20034722D0/no
Publication of NO20034722L publication Critical patent/NO20034722L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20034722A 2002-10-23 2003-10-22 Nye imidazolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO20034722L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0213194A FR2846328B1 (fr) 2002-10-23 2002-10-23 Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (2)

Publication Number Publication Date
NO20034722D0 NO20034722D0 (no) 2003-10-22
NO20034722L true NO20034722L (no) 2004-04-26

Family

ID=29763935

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034722A NO20034722L (no) 2002-10-23 2003-10-22 Nye imidazolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (25)

Country Link
US (2) US6875788B2 (ja)
EP (1) EP1413579B1 (ja)
JP (1) JP2004143167A (ja)
KR (1) KR100642844B1 (ja)
CN (1) CN1234694C (ja)
AR (1) AR041688A1 (ja)
AT (1) ATE288432T1 (ja)
AU (1) AU2003257606A1 (ja)
BR (1) BR0304634A (ja)
CA (1) CA2445817A1 (ja)
DE (1) DE60300307T2 (ja)
DK (1) DK1413579T3 (ja)
EA (1) EA006197B1 (ja)
ES (1) ES2236672T3 (ja)
FR (1) FR2846328B1 (ja)
HK (1) HK1063320A1 (ja)
MA (1) MA27013A1 (ja)
MX (1) MXPA03009576A (ja)
NO (1) NO20034722L (ja)
NZ (1) NZ529084A (ja)
PL (1) PL363022A1 (ja)
PT (1) PT1413579E (ja)
SG (2) SG113482A1 (ja)
SI (1) SI1413579T1 (ja)
ZA (1) ZA200308265B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3214296A1 (en) * 2021-07-08 2023-01-12 China Petroleum & Chemical Corporation Application of naphthenic imidazoline in inhibiting formation of natural gas hydrates and composition containing same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES363246A0 (es) * 1968-02-09 1971-01-16 Scherico Ltd Un procedimiento para preparar nuevas amidinas ciclicas.
US3932431A (en) * 1970-06-24 1976-01-13 Schering Corporation Certain 2-[α(2-pyridyl)-benzyl] imidazolines and derivatives thereof
US4081544A (en) * 1975-12-04 1978-03-28 Schering Corporation Certain 2-(alpha(2-pyridyl)-benzyl)imidazolines and derivatives thereof
CA1330663C (en) * 1987-10-19 1994-07-12 John Michael Berge Thiazolidinedione derivatives
GB8916150D0 (en) * 1989-07-14 1989-08-31 Beecham Group Plc Novel compounds
GB9123857D0 (en) * 1991-11-09 1992-01-02 Smithkline Beecham Plc Novel compounds
CA2085844A1 (en) * 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
JP3416141B2 (ja) * 1994-02-04 2003-06-16 アイシー・ワン・インコーポレイテッド 奨励クレジットの割当て及び割戻し方法及び装置
CA2180891C (en) * 1995-07-12 2010-01-12 Junichi Rekimoto Notification of updates in a three-dimensional virtual reality space sharing system
US5937391A (en) * 1996-07-11 1999-08-10 Fujitsu Limited Point-service system in online shopping mall
US5926179A (en) * 1996-09-30 1999-07-20 Sony Corporation Three-dimensional virtual reality space display processing apparatus, a three-dimensional virtual reality space display processing method, and an information providing medium
US5866579A (en) * 1997-04-11 1999-02-02 Synaptic Pharmaceutical Corporation Imidazole and imidazoline derivatives and uses thereof
US20050203835A1 (en) * 1998-01-30 2005-09-15 Eli Nhaissi Internet billing
GB2351081A (en) * 1999-06-18 2000-12-20 Lilly Forschung Gmbh Pharmaceutically active imidazoline compounds and analogues thereof
US7037194B2 (en) * 2000-03-23 2006-05-02 Atlantic City Coin & Slot Service Company, Inc. Method and device for playing a game
US6672961B1 (en) * 2000-03-16 2004-01-06 Sony Computer Entertainment America Inc. Computer system and method of displaying images
US7383223B1 (en) * 2000-09-20 2008-06-03 Cashedge, Inc. Method and apparatus for managing multiple accounts
US20030118575A1 (en) * 2001-12-11 2003-06-26 Boehringer Ingelheim Pharmaceuticals, Inc. Method for administering BIRB 796 BS
US20050235008A1 (en) * 2002-08-01 2005-10-20 Walt Camping Apparatus and method for collateral recovery
US20050177492A1 (en) * 2002-08-01 2005-08-11 Walt Camping Apparatus and method for asset tracking and recovery
US20050137904A1 (en) * 2003-10-14 2005-06-23 Kathleen Lane System and method for monitoring secured liens
US7882023B2 (en) * 2004-06-23 2011-02-01 Paul Parrish Method and system for managing collateral or property risk in a secured loan or lease portfolio
US7055740B1 (en) * 2004-12-06 2006-06-06 Target Brands, Inc. Stored-value card adapted to be read by an electronic device

Also Published As

Publication number Publication date
SG113482A1 (en) 2005-08-29
EP1413579B1 (fr) 2005-02-02
KR100642844B1 (ko) 2006-11-10
US20040087638A1 (en) 2004-05-06
CN1496982A (zh) 2004-05-19
DE60300307D1 (de) 2005-03-10
SI1413579T1 (en) 2005-06-30
CN1234694C (zh) 2006-01-04
PT1413579E (pt) 2005-05-31
JP2004143167A (ja) 2004-05-20
AU2003257606A1 (en) 2004-05-13
ES2236672T3 (es) 2005-07-16
HK1063320A1 (en) 2004-12-24
AR041688A1 (es) 2005-05-26
CA2445817A1 (fr) 2004-04-23
DE60300307T2 (de) 2006-01-19
KR20040036590A (ko) 2004-04-30
FR2846328B1 (fr) 2004-12-10
DK1413579T3 (da) 2005-05-09
ATE288432T1 (de) 2005-02-15
MA27013A1 (fr) 2004-12-20
NZ529084A (en) 2005-04-29
SG127755A1 (en) 2006-12-29
US6875788B2 (en) 2005-04-05
BR0304634A (pt) 2004-06-01
EA200301045A3 (ru) 2004-08-26
US20050143440A1 (en) 2005-06-30
PL363022A1 (en) 2004-05-04
EP1413579A1 (fr) 2004-04-28
EA200301045A2 (ru) 2004-04-29
FR2846328A1 (fr) 2004-04-30
NO20034722D0 (no) 2003-10-22
EA006197B1 (ru) 2005-10-27
MXPA03009576A (es) 2004-04-29
ZA200308265B (en) 2004-07-09

Similar Documents

Publication Publication Date Title
NO20052683D0 (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20054329D0 (no) Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
NO20042805L (no) Nye forbindelser og deres anvendelse innen medisin, fremgangsmate for deres fremstilling og farmaoytiske sammensetninger som inneholder dem
NO20023643L (no) Forbindelser som har antitumoraktivitet, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholderdem
NO20055835L (no) Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20055167D0 (no) Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20052414L (no) Nye pyrrolidin- og tiazolidinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20043188L (no) Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20052598D0 (no) Nye 2,3-dihydro-4(1H)-pyridonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem.
NO20031219L (no) Nye forbindelser avledet fra kinazolin, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20010305L (no) Nye benzensulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20031643L (no) Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20034614L (no) Nye [3,4-a:3,4-c]karbazolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20041313L (no) Nye isokinolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20042978L (no) Nye benzotiazin- og benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20043910L (no) Nye aminosyreforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20021330D0 (no) Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20052330D0 (no) Nye substituerte [1,4]benzodioksino[2,3]isoindolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20050391D0 (no) Nye fluorinerte benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20035215D0 (no) Tricykliske dihydrokinolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20042422L (no) Nye benzotiazin- og benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20043880L (no) Nye benzoindolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20021198L (no) Nye isoindoloindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20034722L (no) Nye imidazolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application